Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect

SIMPLE SUMMARY: Imiquimod (IMQ), a synthetic ligand of Toll-like receptor 7, is known to exert antitumor effects. However, the exact mechanisms of the IMQ-induced antitumor effect have not been fully understood. Although both topical IMQ treatment and anti-PD-1 antibody may be used for primary skin...

Descripción completa

Detalles Bibliográficos
Autores principales: Oya, Kazumasa, Nakamura, Yoshiyuki, Zhenjie, Zhu, Tanaka, Ryota, Okiyama, Naoko, Ichimura, Yuki, Ishitsuka, Yosuke, Saito, Akimasa, Kubota, Noriko, Watanabe, Rei, Tahara, Hideaki, Fujimoto, Manabu, Fujisawa, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391905/
https://www.ncbi.nlm.nih.gov/pubmed/34439104
http://dx.doi.org/10.3390/cancers13163948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391905/
https://www.ncbi.nlm.nih.gov/pubmed/34439104
http://dx.doi.org/10.3390/cancers13163948

Ejemplares similares